Tofacitinib Therapy for Rheumatoid Arthritis: A Direct Comparison Study between Biologic-naïve and Experienced Patients

OBJECTIVE: This study was designed to directly compare the outcomes of tofacitinib therapy for methotrexate-refractory rheumatoid arthritis (RA) between biologic-naïve patients and patients who had experienced an inadequate response to biological agents. METHODS: We prospectively enrolled and follow...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Yoshitama, Tamami, Ueki, Yukitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874336/
https://www.ncbi.nlm.nih.gov/pubmed/29151519
http://dx.doi.org/10.2169/internalmedicine.9341-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874336/
https://www.ncbi.nlm.nih.gov/pubmed/29151519
http://dx.doi.org/10.2169/internalmedicine.9341-17

Ejemplares similares